Treatment of Severe Pruritus in Dengue Patients
For severe pruritus in dengue patients, use non-sedating antihistamines (such as cetirizine or loratadine) as first-line therapy, combined with emollients for symptomatic relief.
Clinical Context and Approach
Pruritus is a common manifestation in dengue fever, occurring in approximately 33.7% of cases 1. The itching typically appears in the first days of illness and is often associated with skin rash, particularly morbilliform lesions 2. Importantly, patients with skin manifestations and pruritus tend to have a better prognosis than those without rash 2.
Recommended Treatment Algorithm
First-Line Management
Antihistamines: Non-sedating H1-antihistamines are the primary treatment
Emollients: Liberal application for symptomatic relief
- Helps manage xerosis and provides barrier protection
- Should be used regardless of other treatments
Important Contraindications in Dengue
Avoid NSAIDs and aspirin due to bleeding risk from thrombocytopenia - this is a critical safety consideration in dengue management 5. While the general pruritus guidelines 6 mention various systemic agents for other causes of pruritus (gabapentin, mirtazapine, SSRIs), these are not specifically indicated for dengue-associated pruritus and should be reserved for refractory cases after careful risk-benefit assessment.
Clinical Pearls and Monitoring
- The pruritus in dengue is typically self-limited and resolves during the recovery phase
- Monitor for warning signs of severe dengue (plasma leakage, hemorrhage, organ impairment) rather than focusing solely on the pruritus 5
- Patients with pruritus and rash generally require less intensive intervention than those without skin manifestations 2
- Ensure adequate hydration, as this is fundamental to dengue management and may indirectly help with skin symptoms 5
The evidence-based approach prioritizes symptomatic relief with antihistamines while maintaining vigilance for dengue complications, which take precedence over pruritus management in terms of morbidity and mortality outcomes.